Gapping up
In reaction to strong earnings/guidance: ANFI +27.7%, SYUT +6.9%, YGE +3.4%, EZPW +0.6% (also announces private offering of $175 million of cash convertible senior notes due 2019), .
M&A related: GTIV +3.9% (Kindred Healthcare to commence all-cash tender offer to acquire all outstanding shares of Gentiva Health Services for $14.50/share), NUAN +2.3% (ongoing M&A speculation; Media speculation that NUAN is seeking a strategic sale - Oppenheimer envisions $25-30 range), MDT +2.7% (ongoing M&A speculation; positive Barrons mention; multiple analyst upgrades).
A few India related names are trading higher: REDF +4.1%, IBN +2%, SSLT +1.9%, INFY +1.5%, TTM +1.4%
Other news: SAEX +6.4% (announces $150 mln senior secured notes offering), EW +5.6% (announces launch of SAPIEN XT valuve in the U.S.), DARA +4.7% (announced leadership transition; current President and COO Christopher Clement named CEO), MU +2.5% (Micron and SK Hynix may invest in SSD controller IC designers in Taiwan, according to reports), GWPH +1.7% (announces physician reports of Epidiolex treatment effect in children and young adults with treatment-resistant epilepsy from physician-led expanded access treatment program; Data show promising signals), SPEX +1.6% (set to Join Russell Microcap Index), VRTX +1.4% (announces a signed letter of intent to enable public reimbursement of KALYDECO (ivacaftor) in Canada for eligible people with cystic fibrosis), UVE +1.1% (announces authorization of new $10 million share repurchase program), STM +0.9% and SAP +0.8% (still checking), TEVA +0.8% (announced that it has reached settlements with Sandoz, Actavis (ACT), Lupin and Apotex with respect to U.S. Patent 7,132,570), PSEC +0.7% (COO disclosed a 24K common stock purchase at $10.28/share), WFT +0.5% ( announces registration of merger in commercial register of the Canton of Zug ), AAPL +0.3% (Apple has reached a settlement over e-books, according to reports), RDS.A +0.3% (Royal Dutch Shell further reduces its interest in Woodside), TWTR +0.3% (Research suggests that TWTR ads help sales of products, according to reports), WMGI +0.2% (announces commercial launch of INFINITY Total Ankle Replacement System), WMB +0.1% (announces $3 bln Public Offering of Common Stock; also upgraded at Deutsche).
Analyst comments: DSW +2.3% (upgraded to Buy from Neutral at Goldman), LAZ +1.6% (upgraded to Buy from Neutral at UBS)
M&A related: GTIV +3.9% (Kindred Healthcare to commence all-cash tender offer to acquire all outstanding shares of Gentiva Health Services for $14.50/share), NUAN +2.3% (ongoing M&A speculation; Media speculation that NUAN is seeking a strategic sale - Oppenheimer envisions $25-30 range), MDT +2.7% (ongoing M&A speculation; positive Barrons mention; multiple analyst upgrades).
A few India related names are trading higher: REDF +4.1%, IBN +2%, SSLT +1.9%, INFY +1.5%, TTM +1.4%
Other news: SAEX +6.4% (announces $150 mln senior secured notes offering), EW +5.6% (announces launch of SAPIEN XT valuve in the U.S.), DARA +4.7% (announced leadership transition; current President and COO Christopher Clement named CEO), MU +2.5% (Micron and SK Hynix may invest in SSD controller IC designers in Taiwan, according to reports), GWPH +1.7% (announces physician reports of Epidiolex treatment effect in children and young adults with treatment-resistant epilepsy from physician-led expanded access treatment program; Data show promising signals), SPEX +1.6% (set to Join Russell Microcap Index), VRTX +1.4% (announces a signed letter of intent to enable public reimbursement of KALYDECO (ivacaftor) in Canada for eligible people with cystic fibrosis), UVE +1.1% (announces authorization of new $10 million share repurchase program), STM +0.9% and SAP +0.8% (still checking), TEVA +0.8% (announced that it has reached settlements with Sandoz, Actavis (ACT), Lupin and Apotex with respect to U.S. Patent 7,132,570), PSEC +0.7% (COO disclosed a 24K common stock purchase at $10.28/share), WFT +0.5% ( announces registration of merger in commercial register of the Canton of Zug ), AAPL +0.3% (Apple has reached a settlement over e-books, according to reports), RDS.A +0.3% (Royal Dutch Shell further reduces its interest in Woodside), TWTR +0.3% (Research suggests that TWTR ads help sales of products, according to reports), WMGI +0.2% (announces commercial launch of INFINITY Total Ankle Replacement System), WMB +0.1% (announces $3 bln Public Offering of Common Stock; also upgraded at Deutsche).
Analyst comments: DSW +2.3% (upgraded to Buy from Neutral at Goldman), LAZ +1.6% (upgraded to Buy from Neutral at UBS)